La Vecchia C
Istituto di Ricerche Farmacologiche Mario Negri, Università degli Studi di Milano, Milan, Italy.
Proc Soc Exp Biol Med. 1998 Jun;218(2):125-8. doi: 10.3181/00379727-218-44276.
Tomatoes have been estimated as the second most important source of vitamin C, after oranges, in an Italian population. We have therefore considered the relationship between tomato intake and the risk of digestive tract cancers using data from a series of case-control studies conducted in Italy between 1983 and 1992, and including 317 histologically confirmed, incident cases of cancer of the oral cavity and pharynx, 85 of the esophagus, 723 of the stomach, 955 of the colon, and 629 of the rectum, and a total of 2879 controls admitted for acute, non-neoplastic conditions, unrelated to long-term modifications of diet. Multivariate odds ratios (OR) and 95% confidence intervals (CI) for subsequent quartiles of intake of tomatoes were derived, after allowance for age, sex, study center, education, smoking, alcohol drinking, and total calorie intake. There was a consistent pattern of protection for all sites. The ORs for the highest consumption quartile were 0.65 (95% CI 0.4-1.0) for oral cavity, pharynx, and esophagus, 0.43 (95% CI 0.3-0.6) for stomach, 0.39 (95% CI 0.3-0.5) for colon, and 0.42 (95% CI 0.3-0.6) for rectum. Another study of colorectal cancer, based on 1,953 cases and 4,154 controls, conducted between 1992 and 1996 and using a more detailed food frequency questionnaire, confirmed that tomato intake was significantly protective on colorectal cancer risk, even after allowance for several potential confounding factors, including measures of body mass index, calorie intake, and physical activity. The ORs for the highest consumption quintile were 0.79 (95% CI 0.6-0.9) for colon, and 0.71 (95% CI 0.5-0.9) for rectal cancer. The beneficial effect of tomatoes observed in these epidemiological studies may be due to the fact that they constitute one of the most specific features of the Mediterranean diet. This has both a scientific and a public health relevance.
在意大利人群中,据估计番茄是仅次于橙子的第二大重要维生素C来源。因此,我们利用1983年至1992年在意大利进行的一系列病例对照研究的数据,探讨了番茄摄入量与消化道癌症风险之间的关系。这些研究包括317例经组织学确诊的口腔和咽癌新发病例、85例食管癌病例、723例胃癌病例、955例结肠癌病例和629例直肠癌病例,以及总共2879名因急性非肿瘤性疾病入院的对照者,这些疾病与长期饮食改变无关。在考虑了年龄、性别、研究中心、教育程度、吸烟、饮酒和总热量摄入等因素后,得出了番茄摄入量后续四分位数的多变量优势比(OR)和95%置信区间(CI)。所有部位都呈现出一致的保护模式。口腔、咽和食管癌最高消费四分位数的OR为0.65(95%CI 0.4 - 1.0),胃癌为0.43(95%CI 0.3 - 0.6),结肠癌为0.39(95%CI 0.3 - 0.5),直肠癌为0.42(95%CI 0.3 - 0.6)。另一项基于1953例病例和4154名对照者的结直肠癌研究,于1992年至1996年进行,并使用了更详细的食物频率问卷,证实即使在考虑了几个潜在的混杂因素后,包括体重指数、热量摄入和身体活动的测量值,番茄摄入量对结直肠癌风险仍有显著的保护作用。结肠癌最高消费五分位数的OR为0.79(95%CI 0.6 - 0.9),直肠癌为0.71(95%CI 0.5 - 0.9)。在这些流行病学研究中观察到的番茄的有益作用可能是因为它们是地中海饮食最具特色的组成部分之一。这具有科学和公共卫生方面的意义。